BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37592819)

  • 1. Current magnetic resonance imaging-based diagnostic strategies for prostate cancer.
    Inoue T; Shin T
    Int J Urol; 2023 Dec; 30(12):1078-1086. PubMed ID: 37592819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status and future prospective of focal therapy for localized prostate cancer: development of multiparametric MRI, MRI-TRUS fusion image-guided biopsy, and treatment modalities.
    Shoji S; Hiraiwa S; Hanada I; Kim H; Nitta M; Hasegawa M; Kawamura Y; Hashida K; Tajiri T; Miyajima A
    Int J Clin Oncol; 2020 Apr; 25(4):509-520. PubMed ID: 32040781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unilateral lesion detected on preoperative multiparametric magnetic resonance imaging and MRI/US fusion-guided prostate biopsy is not an appropriate indication for focal therapy in prostate cancer.
    Zhou Z; Zhou Y; Yan W; Sun H; Li Q; Li H; Ji Z
    Urol Oncol; 2021 Oct; 39(10):730.e17-730.e22. PubMed ID: 34175215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review.
    Valerio M; Donaldson I; Emberton M; Ehdaie B; Hadaschik BA; Marks LS; Mozer P; Rastinehad AR; Ahmed HU
    Eur Urol; 2015 Jul; 68(1):8-19. PubMed ID: 25454618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric MRI-ultrasonography software fusion prostate biopsy: initial results using a stereotactic robotic-assisted transperineal prostate biopsy platform comparing systematic vs targeted biopsy.
    Lee AYM; Yang XY; Lee HJ; Law YM; Huang HH; Lau WKO; Lee LS; Ho HSS; Tay KJ; Cheng CWS; Yuen JSP; Chen K
    BJU Int; 2020 Nov; 126(5):568-576. PubMed ID: 32438463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted and Systematic Biopsy for the Diagnosis and Management of Prostate Cancer - A Case for Lesion Targeted-Only Biopsies.
    Tam JO; Ahmed HU
    Clin Oncol (R Coll Radiol); 2020 Mar; 32(3):136-143. PubMed ID: 32035580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI-Targeted Prostate Biopsy: What Radiologists Should Know.
    Das CJ; Netaji A; Razik A; Verma S
    Korean J Radiol; 2020 Sep; 21(9):1087-1094. PubMed ID: 32691544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cohort of transperineal electromagnetically tracked magnetic resonance imaging/ultrasonography fusion-guided biopsy: assessing the impact of inter-reader variability on cancer detection.
    Wajswol E; Winoker JS; Anastos H; Falagario U; Okhawere K; Martini A; Treacy PJ; Voutsinas N; Knauer CJ; Sfakianos JP; Lewis SC; Taouli BA; Rastinehad AR
    BJU Int; 2020 Apr; 125(4):531-540. PubMed ID: 31762182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transperineal Multiparametric Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy Combined with Standard Template Improves Prostate Cancer Detection.
    Kim MM; Wu S; Lin SX; Crotty RK; Harisinghani M; Feldman AS; Wu CL; Dahl DM
    J Urol; 2022 Jan; 207(1):86-94. PubMed ID: 34428921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of initial and second opinion reads of multiparametric magnetic resonance imaging of the prostate for transperineal template-guided biopsies with MRI-Ultrasound fusion.
    Ecke TH; Schwaiger D; Nesterov G; Koswig S; Selinski S; Barrett T; Gnanapragasam V; Koch S; Hallmann S
    Urol Oncol; 2021 Nov; 39(11):781.e1-781.e7. PubMed ID: 33563540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging-transrectal ultrasound image fusion guidance of prostate biopsies: current status, challenges and future perspectives.
    Boesen L
    Scand J Urol; 2019; 53(2-3):89-96. PubMed ID: 31006323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging and Fusion Guided Targeted Biopsy Evaluated by Transperineal Template Saturation Prostate Biopsy for the Detection and Characterization of Prostate Cancer.
    Mortezavi A; Märzendorfer O; Donati OF; Rizzi G; Rupp NJ; Wettstein MS; Gross O; Sulser T; Hermanns T; Eberli D
    J Urol; 2018 Aug; 200(2):309-318. PubMed ID: 29474846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Magnetic Resonance Imaging Targeting on Overdiagnosis and Overtreatment of Prostate Cancer.
    Vickers AJ
    Eur Urol; 2021 Nov; 80(5):567-572. PubMed ID: 34294510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-Bore MRI-guided Prostate Biopsies: Retrospective Observational Study of Complementary Nontargeted Sampling of Normal-appearing Areas at Multiparametric MRI.
    Elfatairy KK; Filson CP; Sanda MG; Osunkoya AO; Nour SG
    Radiol Imaging Cancer; 2019 Nov; 1(2):e190016. PubMed ID: 33778681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic and MRI-Cognitive Targeted Transperineal Prostate Biopsy Accuracy in Detecting Clinically Significant Prostate Cancer after Previous Negative Biopsy and Persisting Suspicion of Malignancy.
    Vėželis A; Platkevičius G; Kinčius M; Gumbys L; Naruševičiūtė I; Briedienė R; Petroška D; Ulys A; Jankevičius F
    Medicina (Kaunas); 2021 Jan; 57(1):. PubMed ID: 33435132
    [No Abstract]   [Full Text] [Related]  

  • 16. mpMRI-targeted biopsy versus systematic biopsy for clinically significant prostate cancer diagnosis: a systematic review and metaanalysis.
    Baccaglini W; Glina FPA; Pazeto CL; Bernardo WM; Sanchez-Salas R
    Curr Opin Urol; 2020 Sep; 30(5):711-719. PubMed ID: 32732624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study.
    Rouvière O; Puech P; Renard-Penna R; Claudon M; Roy C; Mège-Lechevallier F; Decaussin-Petrucci M; Dubreuil-Chambardel M; Magaud L; Remontet L; Ruffion A; Colombel M; Crouzet S; Schott AM; Lemaitre L; Rabilloud M; Grenier N;
    Lancet Oncol; 2019 Jan; 20(1):100-109. PubMed ID: 30470502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [MRI of the prostate].
    Nörenberg D; Solyanik O; Schlenker B; Magistro G; Ertl-Wagner B; Clevert DA; Stief C; Reiser MF; D'Anastasi M
    Urologe A; 2017 May; 56(5):665-677. PubMed ID: 28424829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Multiparametric Magnetic Resonance Imaging and Targeted Biopsy With Systematic Biopsy Alone for the Diagnosis of Prostate Cancer: A Systematic Review and Meta-analysis.
    Elwenspoek MMC; Sheppard AL; McInnes MDF; Merriel SWD; Rowe EWJ; Bryant RJ; Donovan JL; Whiting P
    JAMA Netw Open; 2019 Aug; 2(8):e198427. PubMed ID: 31390032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial.
    Tonttila PP; Lantto J; Pääkkö E; Piippo U; Kauppila S; Lammentausta E; Ohtonen P; Vaarala MH
    Eur Urol; 2016 Mar; 69(3):419-25. PubMed ID: 26033153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.